83 related articles for article (PubMed ID: 26420578)
1. Response to: 'Role of nerve growth factor (NGF) and tropomyosin receptor kinase A (TrkA) in the pathogenesis of osteoarthritis. Might NGF be the link interwinding obesity and OA?' by Iannone et al.
Nwosu LN; Walsh DA
Ann Rheum Dis; 2015 Dec; 74(12):e71. PubMed ID: 26420578
[No Abstract] [Full Text] [Related]
2. Role of nerve growth factor and tropomyosin receptor kinase A in the pathogenesis of osteoarthritis. Might nerve growth factor be the link interwinding obesity and osteoarthritis?
Iannone F; Perniola S; Lopalco G; Cantarini L; Lapadula G
Ann Rheum Dis; 2015 Dec; 74(12):e70. PubMed ID: 26386127
[No Abstract] [Full Text] [Related]
3. A tale of two TrkA inhibitor trials: same target, divergent results.
Walsh DA; Neogi T
Osteoarthritis Cartilage; 2019 Nov; 27(11):1575-1577. PubMed ID: 31356877
[No Abstract] [Full Text] [Related]
4. Antagonism of nerve growth factor-TrkA signaling and the relief of pain.
Mantyh PW; Koltzenburg M; Mendell LM; Tive L; Shelton DL
Anesthesiology; 2011 Jul; 115(1):189-204. PubMed ID: 21602663
[TBL] [Abstract][Full Text] [Related]
5. Novel class of pain drugs based on antagonism of NGF.
Hefti FF; Rosenthal A; Walicke PA; Wyatt S; Vergara G; Shelton DL; Davies AM
Trends Pharmacol Sci; 2006 Feb; 27(2):85-91. PubMed ID: 16376998
[TBL] [Abstract][Full Text] [Related]
6. Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint pain.
McNamee KE; Burleigh A; Gompels LL; Feldmann M; Allen SJ; Williams RO; Dawbarn D; Vincent TL; Inglis JJ
Pain; 2010 May; 149(2):386-392. PubMed ID: 20350782
[TBL] [Abstract][Full Text] [Related]
7. Analgesia via blockade of NGF/TrkA signaling does not influence fracture healing in mice.
Rapp AE; Kroner J; Baur S; Schmid F; Walmsley A; Mottl H; Ignatius A
J Orthop Res; 2015 Aug; 33(8):1235-41. PubMed ID: 25876530
[TBL] [Abstract][Full Text] [Related]
8. Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats.
Enomoto M; Mantyh PW; Murrell J; Innes JF; Lascelles BDX
Vet Rec; 2019 Jan; 184(1):23. PubMed ID: 30368458
[TBL] [Abstract][Full Text] [Related]
9. Nerve growth factor enhances cough and airway obstruction via TrkA receptor- and TRPV1-dependent mechanisms.
El-Hashim AZ; Jaffal SM
Thorax; 2009 Sep; 64(9):791-7. PubMed ID: 19497920
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of tropomyosin-receptor-kinase A (TrkA) reduces pain and joint damage in two rat models of inflammatory arthritis.
Ashraf S; Bouhana KS; Pheneger J; Andrews SW; Walsh DA
Arthritis Res Ther; 2016 May; 18(1):97. PubMed ID: 27145816
[TBL] [Abstract][Full Text] [Related]
11. NGF receptor TrkAd5: therapeutic agent and drug design target.
Dawbarn D; Fahey M; Watson J; Tyler S; Shoemark D; Sessions R; Zhang R; Brady L; Willis C; Allen SJ
Biochem Soc Trans; 2006 Aug; 34(Pt 4):587-90. PubMed ID: 16856868
[TBL] [Abstract][Full Text] [Related]
12. Mechanism and therapeutic effectiveness of nerve growth factor in osteoarthritis pain.
Shang X; Wang Z; Tao H
Ther Clin Risk Manag; 2017; 13():951-956. PubMed ID: 28814877
[TBL] [Abstract][Full Text] [Related]
13. NGF/TrkA Signaling as a Therapeutic Target for Pain.
Hirose M; Kuroda Y; Murata E
Pain Pract; 2016 Feb; 16(2):175-82. PubMed ID: 26452158
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of PLC-gamma1 activity converts nerve growth factor from an anti-mitogenic to a mitogenic signal in CHO cells.
Zapf-Colby A; Eichhorn J; Webster NJ; Olefsky JM
Oncogene; 1999 Sep; 18(35):4908-19. PubMed ID: 10490825
[TBL] [Abstract][Full Text] [Related]
15. Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factor-alpha, interleukin-1 beta and cholecystokinin-8: the possible role of NGF in the inflammatory response.
Manni L; Lundeberg T; Fiorito S; Bonini S; Vigneti E; Aloe L
Clin Exp Rheumatol; 2003; 21(5):617-24. PubMed ID: 14611111
[TBL] [Abstract][Full Text] [Related]
16. A role for trkA nerve growth factor receptors in mammalian ovulation.
Dissen GA; Hill DF; Costa ME; Les Dees CW; Lara HE; Ojeda SR
Endocrinology; 1996 Jan; 137(1):198-209. PubMed ID: 8536613
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of nerve growth factor antibody in a knee osteoarthritis pain model in mice.
Miyagi M; Ishikawa T; Kamoda H; Suzuki M; Inoue G; Sakuma Y; Oikawa Y; Orita S; Uchida K; Takahashi K; Takaso M; Ohtori S
BMC Musculoskelet Disord; 2017 Nov; 18(1):428. PubMed ID: 29100502
[TBL] [Abstract][Full Text] [Related]
18. Overexpressions of nerve growth factor and its tropomyosin-related kinase A receptor on chordoma cells.
Park JB; Lee CK; Koh JS; Lee JK; Park EY; Riew KD
Spine (Phila Pa 1976); 2007 Aug; 32(18):1969-73. PubMed ID: 17700442
[TBL] [Abstract][Full Text] [Related]
19. The regulatory role of nerve growth factor and its receptor system in fibroblast-like synovial cells.
Raychaudhuri SP; Raychaudhuri SK
Scand J Rheumatol; 2009; 38(3):207-15. PubMed ID: 19177265
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro.
Festuccia C; Muzi P; Gravina GL; Millimaggi D; Speca S; Dolo V; Ricevuto E; Vicentini C; Bologna M
Int J Oncol; 2007 Jan; 30(1):193-200. PubMed ID: 17143529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
